BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2025 9:15:13 AM | Browse: 334 | Download: 771
Publication Name World Journal of Stem Cells
Manuscript ID 103100
Country Italy
Received
2024-11-08 08:26
Peer-Review Started
2024-11-08 08:26
First Decision by Editorial Office Director
2025-02-10 08:43
Return for Revision
2025-02-10 08:43
Revised
2025-02-17 12:52
Publication Fee Transferred
Editorial Processing by Scientific Editor
2025-04-15 02:44
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2025-04-16 10:57
Articles in Press
2025-04-16 10:57
Edit the Manuscript by Language Editor
2025-05-06 04:46
Typeset the Manuscript
2025-05-19 03:51
Publish the Manuscript Online
2025-05-26 09:15
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Ophthalmology
Manuscript Type Review
Article Title Stem cell therapy for retinal pigment epithelium disorders
Manuscript Source Invited Manuscript
All Author List Francesco Saverio Sorrentino, Francesco Parmeggiani, Lorenzo Gardini, Luigi Fontana, Mutali Musa, Caterina Gagliano and Marco Zeppieri
ORCID
Author(s) ORCID Number
Mutali Musa http://orcid.org/0000-0001-7486-8361
Caterina Gagliano http://orcid.org/0000-0001-8424-0068
Marco Zeppieri http://orcid.org/0000-0003-0999-5545
Funding Agency and Grant Number
Corresponding Author Marco Zeppieri, MD, PhD, Department of Ophthalmology, University Hospital of Udine, p. le S. Maria della Misericordia 15, Udine 33100, Italy. mark.zeppieri@asufc.sanita.fvg.it
Key Words Cell transplantation; Molecular stem cell mechanisms; Retinal degeneration; Stem cell therapy; Retinal pigment epithelium
Core Tip There has been significant progress in research on the retinal pigment epithelium (RPE), with a particular focus on stem cell therapies and molecular discoveries that have the potential to treat retinopathies. The RPE is crucial for vision and the health of the eye. Studies have shown the potential of using stem cell-derived RPE to cure retinopathies in their early stages. Understanding the molecular and genetic mechanisms that are involved in the development and differentiation of RPE are fundamental when searching for novel therapeutic approaches.
Publish Date 2025-05-26 09:15
Citation

Sorrentino FS, Parmeggiani F, Gardini L, Fontana L, Musa M, Gagliano C, Zeppieri M. Stem cell therapy for retinal pigment epithelium disorders. World J Stem Cells 2025; 17(5): 103100

URL https://www.wjgnet.com/1948-0210/full/v17/i5/103100.htm
DOI https://dx.doi.org/10.4252/wjsc.v17.i5.103100
Full Article (PDF) WJSC-17-103100-with-cover.pdf